Navigation Links
Drug Solubility Technology: Spray Drying, Extrusion, and SCF
Date:12/2/2013

DUBLIN, December 2, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/652296/drug_solubility) has announced the addition of the "Drug Solubility Technology: Spray Drying, Extrusion, and SCF" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


Processes , Products and Prospects

As drug suppliers re-examine their business models to adjust to the rapidly evolving competitive landscape, the importance and impact of drug solubility on drug design and development is increasing in importance, extending beyond potential future drug therapeutics, and affecting current reformulation strategies as well. As large-molecule therapeutics increase in number and as a percentage of all drug discoveries, the economic scales will tip in favor of those drug developers possessing the ability to engineer water-soluble formulations of inherently hydrophobic compounds. The importance of solubilization technologies is also underscored by the capability they bestow on formulators attempting to re-formulate approved drugs approaching the end of their patent life.

The survey examines established physical processes for improving and enhancing drug solubility, including spray dry dispersion, hot melt extrusion and supercritical fluid processing.


Highlights

- Analyzes and evaluates drug formulation process technology improving the properties of insoluble poorly soluble and/or poorly absorbed drug candidates

- Examines evolving market factors

- Provides detailed assessments and status of commercial technologies designed to improve drug solubility

- Profiles drug solubility technology market participants, their research activity, proprietary technology, and business strategies

Key Topics Covered

Executive Summary

Drug Solubility Technology

Spray Dry Dispersion
Technology Market Drivers
Physicochemical Properties
Hot Melt Extrusion
Supercritical Fluid Processing


Approved Drug Products Formulated with SDD/HME/SFP

Acetaminophen
Nifedipine
Everolimus
Nabilone
Diethylpropion
Emend
Vildagliptin/Metformin
Clozapine
Fenofibrate
Griseofulvin
Ibuprofen
Etonogestrel
Etravirine
Verapamil
Liponavir+Ritonavir
Lacrisert
Tacrolimus
Rizatriptan
Naproxen
Norvir
Tapentadol
Etonogestrel, Ethinyl Estradiol
Itraconazole
Dexamethasone
Hydromorphone
Rapamune
Tricor, Triglide
Zoladex


Development/Pipeline Analysis and Assessment

Company Profiles

For more information visit http://www.researchandmarkets.com/research/652296/drug_solubility

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hovione and Solvias Announce a Collaboration to Provide for Improved Drug Solubility
2. Pharma IQs Solubility Report
3. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
4. Agricultural Biotechnology: Emerging Technologies and Global Markets
5. Mission Pharmacal Launches Aquoral Oral Spray for Dry Mouth
6. Considering Corticosteroid Nasal Sprays
7. North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 20
8. Aegis Awarded 2nd Patent for Fast Acting Migraine Nasal Spray Treatment
9. Remedium Technologies Inc. Awarded $500,000 Phase II NSF SBIR Grant to Test Sprayable Foam for Stopping Traumatic Bleeding
10. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Site Profile: --> Site ... People, announced their latest primary healthcare case study where speech recognition ... and to save the practice money. Site Profile: ... Challenge: --> ,- Wirral CCG ,- VoicePower client since ... Wirral CCG ,- VoicePower client since 2013 Challenge: ...
(Date:2/5/2016)... Feb. 5, 2016 ... the "Global Obstetrics Partnering 2010-2016: Deal ... to their offering. --> http://www.researchandmarkets.com/research/hcdvg6/global_obstetrics ... "Global Obstetrics Partnering 2010-2016: Deal trends, ... their offering. --> Research and ...
(Date:2/4/2016)...  Edwards Lifesciences Corporation (NYSE: EW ), the ... and critical care monitoring, announced today that it has ... Morgan Stanley & Co. LLC to repurchase $325 million ... the Company,s previously authorized program to repurchase up to ... --> --> Under the ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air ... variety of colors, assortments and packaging. This staple for Valentine’s Day is a must-have, ... , For Valentine’s Day, not only are long-stem roses available, but also other ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular Dystrophy Association and ... launched the 14th annual “Appetite for a Cure” campaign on Feb. 1 to ... and related diseases that severely limit strength and mobility. , Now through ...
(Date:2/5/2016)... Miami, Florida (PRWEB) , ... February 05, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – is poised to once again host, Swirl, A Wine Tasting Event ...
(Date:2/5/2016)... ... ... Give To Cure today announced that it is working with ... Cure’s campaign that is crowdfunding clinical trials to help find cures faster for Alzheimer’s ... smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is ... to provide the most effective tattoo removal today, Dr. Bentkover is the only doctor ... by Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) ...
Breaking Medicine News(10 mins):